The Food and Drug Administration today authorized Moderna’s COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer’s COVID-19 vaccine for children aged 6 months through 4 years old, as recommended this week by its vaccine advisory committee. The vaccines previously were authorized for older children.
 
Before vaccinations can begin, the Centers for Disease Control and Prevention must recommend the vaccines for these age groups. CDC’s Advisory Committee on Immunization Practices is scheduled to vote tomorrow on whether to authorize the vaccines for children age 5 and under.
 

Related News Articles

Headline
The Food & Drug Administration last week revised its Evusheld fact sheet for health care providers, recommending repeat dosing every six months if patients…
Headline
The departments of Health and Human Services and Defense yesterday announced an agreement to purchase at least 105 million doses of a Pfizer omicron-…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration this week…
Headline
The Centers for Disease Control and Prevention last night endorsed Moderna’s COVID-19 vaccine for children aged 6-17, as its advisory committee…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices on Saturday recommended the Moderna vaccine for children aged 6…